Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT00818350
Eligibility Criteria:
Inclusion Criteria:
* cytological confirmation of UROTHELIAL carcinoma
* Failure of Cisplatin-gemcitabine regimen as first-line
* Presence of measurable metastases
* Performance status 0-1 ECOG
* Age of 18 years or older
* Written informed consent
* Adequate organ function ( based on tests of hematologic, hepatic, renal and cardiac function).
Exclusion Criteria:
* administration of a previous biological therapy ( sorafenib , bevacizumab or mTor Inhibitor)
* brain metastases
* significant cardiac events within the 6 months prior to study drug administration.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00818350
Study Brief:
Protocol Section:
NCT00818350